Applying for a grant
To date SRUK has funded more than £10 million worth of scientific and medical research that has helped improve the lives of people affected by Scleroderma and Raynaud's phenomenon.
Next grants call in Spring 2019
At Scleroderma and Raynaud's UK, we believe that investing in research is the key to securing a future where no one has their lives limited by Scleroderma and Raynaud's.
To maximise our investment into research, we are currently working to further develop our research strategy so that we can fund and accelerate those areas of research that will translate into significant benefits for our community of people living with Scleroderma and Raynaud's.
To help us ensure that our donor's generous support is invested in ways that will translate into innovative and impactful opportunities for researchers, such as themed funding calls, we are going to open our next grants call in Spring 2019.
This will allow us time to work with our communities of patients, clinicians and researchers to understand more fully the needs of people with scleroderma and Raynaud's as well as identify the current unmet needs within research that require crucial support. We believe that it is this collaborative approach that will allow us all to make the significant change that is so desperately needed.
If you'd like to be involved in the development of our research strategy, then please do not hesitate to get in touch with our Head of Research and Services, Dr Fatima Ann Sulaiman email@example.com.
SRUK is committed to continue investing in research to improve understanding and treatment of the conditions until, ultimately, we find a cure. Application deadlines are competitively reviewed and successful applications will be awarded in late spring/early summer of that year.
Applications for travel grants to attend and/or present at scientific meetings do not need to go through the standard application and review process as they are for much smaller sums of money. Decisions to award travel grants will be made by the trustees on a case-by-case basis based on the merit of the application.